{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361137044973470208.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/s0168-8278(09)60919-3"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0168827809609193?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0168827809609193?httpAccept=text/plain"}}],"dc:title":[{"@value":"917 ON-TREATMENT MONITORING OF HBsAg LEVELS TO PREDICT RESPONSE TO PEGINTERFERON ALFA-2A IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381137044973470082","@type":"Researcher","foaf:name":[{"@value":"G.K.K. Lau"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044973470083","@type":"Researcher","foaf:name":[{"@value":"P. Marcellin"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044973470084","@type":"Researcher","foaf:name":[{"@value":"M. Brunetto"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044973470085","@type":"Researcher","foaf:name":[{"@value":"T. Piratvisuth"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044973470081","@type":"Researcher","foaf:name":[{"@value":"H.-P. Kapprell"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044973470208","@type":"Researcher","foaf:name":[{"@value":"D. Messinger"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044973470080","@type":"Researcher","foaf:name":[{"@value":"M. Popescu"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"01688278"}],"prism:publicationName":[{"@value":"Journal of Hepatology"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2009-04","prism:volume":"50","prism:startingPage":"S333"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0168827809609193?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0168827809609193?httpAccept=text/plain"}],"createdAt":"2009-05-22","modifiedAt":"2018-12-19","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360565168116348928","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"JSH Guidelines for the Management of Hepatitis B Virus Infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679771619840","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Two cases of acute hepatitis due to hepatitis E virus that are indigenous to Kitakyushu: a case report"},{"@language":"ja","@value":"北九州に土着したE型肝炎ウイルス株による急性肝炎の2例"},{"@value":"B型肝炎治療ガイドライン(第1.1版)"},{"@language":"ja-Kana","@value":"Bガタ カンエン チリョウ ガイドライン(ダイ1.1ハン)"},{"@language":"ja-Kana","@value":"キタキュウシュウ ニ ドチャク シタ Eガタ カンエンウイルスカブ ニ ヨル キュウセイ カンエン ノ 2レイ"},{"@value":"Guidelines for the management of hepatitis B virus infection"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/s0168-8278(09)60919-3"},{"@type":"CROSSREF","@value":"10.1111/hepr.12269_references_DOI_M1kMmZENMLiVTH4PI8Xv6pTzHSN"},{"@type":"CROSSREF","@value":"10.2957/kanzo.54.402_references_DOI_M1kMmZENMLiVTH4PI8Xv6pTzHSN"}]}